Hi all,

for samples collected in a clinical trial to be used for exploratory endpoints purposes (for example gene expression differences), are these also subject to the same regulations for clinical samples used to assess clinical endpoints or safety? Do the lab staff also need to have GCP training? Is it possible that these labs get inspected?